<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01071447</url>
  </required_header>
  <id_info>
    <org_study_id>FoUS09001</org_study_id>
    <nct_id>NCT01071447</nct_id>
  </id_info>
  <brief_title>Nurse-led Clinic for Patients With Rheumatic Diseases and Biological Treatment</brief_title>
  <official_title>Nurse-led Clinic for Patients With Rheumatic Diseases and Biological Treatment:a Randomized Controlled Trial Comparing Nurse-led Clinic Versus Rheumatologist Clinic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spenshult Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Swedish Rheumatism Ass</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>County Council of Halland, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Spenshult Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled trial including 100 subjects with rheumatic diseases and biological
      treatment with a 28 point-Disease Activity Score(DAS28)3.2 or less. The subjects will be
      randomized to either nurse-led clinic or rheumatologist-led clinic. The hypothesis is that
      there will be no difference in DAS28 between the two groups after 1 year follow-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim To compare nurse-led clinic and rheumatologist-led clinic regarding results of treatment,
      and health economic costs.

      Intervention Rheumatologist-led clinic: The subjects are seeing a rheumatologist after six
      months and after 12-months of intervention and have the possibility to contact the
      rheumatology clinic.

      Nurse-led clinic: The subjects are seeing a rheumatology nurse after six months and a
      rheumatologist after 12 months of intervention and have the possibility to contact the
      rheumatology nurse during the intervention.

      Outcome measures:

      Main outcome: DAS28 and costs for the clinics respectively.

      Secondary outcome: HAQ (Health Assessment Questionnaire), VAS-pain (Visual Analog Scale),
      VAS-global health, VAS-satisfaction, VAS-security/trust, Tender joints, swollen joints,
      Quality of life-EQ5D, Effective consumer survey 17, Inflammatory parameters in blood.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2009</start_date>
  <completion_date type="Anticipated">October 2012</completion_date>
  <primary_completion_date type="Anticipated">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>DAS28 and costs for the clinics respectively.</measure>
    <time_frame>Baseline at 0 months, 6 months, 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>HAQ (Health Assessment Questionnaire), VAS-pain (Visual Analog Scale), VAS-global health, VAS-satisfaction, VAS-security/trust, Tender joints, swollen joints, Quality of life-EQ5D, Effective consumer survey 17, Inflammatory parameters in blood.</measure>
    <time_frame>Baseline at 0 months, 6 months, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Rheumatic Diseases</condition>
  <arm_group>
    <arm_group_label>Rheumatologist-led clinic</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Rheumatologist-led clinic: The subjects are seeing a rheumatologist after six months and after 12-months of intervention and have the possibility to contact the rheumatology clinic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nurse-led clinic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects are seeing a rheumatology nurse after six months and a rheumatologist after 12 months of intervention and have the possibility to contact the rheumatology nurse during the intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nurse-led clinic vs rheumatologist-led clinic</intervention_name>
    <description>The subjects are seeing a rheumatology nurse (experimental arm)instead of a rheumatologist (active comparator arm) after six months. Subjects in both arms are seeing a rheumatologist after 12 months and have the possibility to contact the rheumatology nurse.</description>
    <arm_group_label>Rheumatologist-led clinic</arm_group_label>
    <arm_group_label>Nurse-led clinic</arm_group_label>
    <other_name>Nurse-led clinic</other_name>
    <other_name>Rheumatologist-led clinic</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with rheumatologic diseases and biological treatment with a DAS28 of 3.2 or
             less

        Exclusion Criteria:

          -  The subjects should not have problems with infections due to treatment

          -  Subjects with difficulties speaking and/or reading swedish
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ingrid Larsson, RN, PhD-stud</last_name>
    <role>Principal Investigator</role>
    <affiliation>R&amp;D-centre Spenshult</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefan Bergman, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>R&amp;D-centre Spenshult</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Barbro Arvidsson, RNT, prof</last_name>
    <role>Study Chair</role>
    <affiliation>R&amp;D-centre Spenshult</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bengt Fridlund, RNT, prof</last_name>
    <role>Study Chair</role>
    <affiliation>University of Jönköping, Sweden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Bergman, MD, PhD</last_name>
    <phone>+46-35 2635250</phone>
    <email>stefan.bergman@spenshult.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ingrid Larsson, RN, PhD-stud</last_name>
    <phone>+46-35 2635253</phone>
    <email>ingrid.larsson@spenshult.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Spenshult Hospital</name>
      <address>
        <city>Oskarström</city>
        <zip>S-31392</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Bergman, MD, PhD</last_name>
      <phone>+46-35 2635050</phone>
      <email>stefan.bergman@spenshult.se</email>
    </contact>
    <contact_backup>
      <last_name>Ingrid Larsson, RN, PhD-stud</last_name>
      <phone>+46-35 2635253</phone>
      <email>ingrid.larsson@spenshult.se</email>
    </contact_backup>
    <investigator>
      <last_name>Ingrid Larsson, RN, PhD-stud</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <link>
    <url>http://www.fou-spenshult.se</url>
  </link>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2009</study_first_submitted>
  <study_first_submitted_qc>February 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2010</study_first_posted>
  <last_update_submitted>August 17, 2010</last_update_submitted>
  <last_update_submitted_qc>August 17, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2010</last_update_posted>
  <responsible_party>
    <name_title>Stefan Bergman, Research Director</name_title>
    <organization>R&amp;D-centre Spenshult Hospital</organization>
  </responsible_party>
  <keyword>Rheumatic diseases</keyword>
  <keyword>Biologic treatment</keyword>
  <keyword>Nurse-led</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rheumatic Diseases</mesh_term>
    <mesh_term>Collagen Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

